Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 10, 2019

Primary Completion Date

May 31, 2026

Study Completion Date

August 31, 2026

Conditions
Opioid-use Disorder
Interventions
BEHAVIORAL

imFREE mCBT

The imFREE condition is a 32-week tailored, interactive text messaging intervention targeting buprenorphine treatment retention and adherence as well as opioid use and associated health consequences. Following a face-to-face CBT session with a clinician, participants receive CBT skills training via daily text messaging, with content themes around relapse prevention, adherence behaviors, and personalized plans to overcome risk factors for treatment discontinuation.

BEHAVIORAL

mHealth ED

The mHealth condition will provide participants with a manualized health psychoeducation session of equivalent duration to the face-to-face CBT session delivered to imFREE participants. Content focuses on various dimensions of health and well-being. Subsequent to this session participants will receive an informational pamphlet regarding BUP and the importance of adherence. the mHealth component of the intervention comprises text reminders for scheduled MM appointments.

Trial Locations (1)

91356

Tarzana Treatment Center, Tarzana

All Listed Sponsors
collaborator

University of California, San Diego

OTHER

lead

University of California, Los Angeles

OTHER

NCT04808479 - Effectiveness of a CBT-based mHealth Intervention Targeting MOUD Retention, Adherence, and Opioid Use | Biotech Hunter | Biotech Hunter